nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—Methylprednisolone—ankylosing spondylitis	0.123	0.254	CbGbCtD
Bepridil—ABCB1—Betamethasone—ankylosing spondylitis	0.0797	0.165	CbGbCtD
Bepridil—ABCB1—Prednisolone—ankylosing spondylitis	0.0786	0.163	CbGbCtD
Bepridil—ABCB1—Prednisone—ankylosing spondylitis	0.0743	0.154	CbGbCtD
Bepridil—ABCB1—Dexamethasone—ankylosing spondylitis	0.0464	0.0961	CbGbCtD
Bepridil—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0437	0.0905	CbGbCtD
Bepridil—ABCB1—Methotrexate—ankylosing spondylitis	0.0373	0.0772	CbGbCtD
Bepridil—CALM3—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0179	0.0548	CbGpPWpGaD
Bepridil—CALM2—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0173	0.053	CbGpPWpGaD
Bepridil—CALM1—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0173	0.053	CbGpPWpGaD
Bepridil—ATP1A1—Ion channel transport—ANO6—ankylosing spondylitis	0.0125	0.0382	CbGpPWpGaD
Bepridil—CALM3—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0117	0.036	CbGpPWpGaD
Bepridil—CALM2—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0114	0.0348	CbGpPWpGaD
Bepridil—CALM1—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0114	0.0348	CbGpPWpGaD
Bepridil—CALM3—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0113	0.0347	CbGpPWpGaD
Bepridil—CALM2—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.011	0.0336	CbGpPWpGaD
Bepridil—CALM1—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.011	0.0336	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00806	0.0247	CbGpPWpGaD
Bepridil—CACNA1A—Type II diabetes mellitus—TNF—ankylosing spondylitis	0.00574	0.0176	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00556	0.017	CbGpPWpGaD
Bepridil—KCNH2—Hematopoietic Stem Cell Differentiation—IL1A—ankylosing spondylitis	0.0044	0.0135	CbGpPWpGaD
Bepridil—ATP1A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00434	0.0133	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.004	0.0123	CbGpPWpGaD
Bepridil—Loss of libido—Methotrexate—ankylosing spondylitis	0.00398	0.0208	CcSEcCtD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00398	0.0122	CbGpPWpGaD
Bepridil—Sudden death—Methotrexate—ankylosing spondylitis	0.00359	0.0188	CcSEcCtD
Bepridil—PDE1A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00328	0.0101	CbGpPWpGaD
Bepridil—CACNA1H—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.00305	0.00936	CbGpPWpGaD
Bepridil—PDE1B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.003	0.0092	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00298	0.00914	CbGpPWpGaD
Bepridil—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.00275	0.00843	CbGpPWpGaD
Bepridil—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.00266	0.00816	CbGpPWpGaD
Bepridil—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.00266	0.00816	CbGpPWpGaD
Bepridil—PDE1A—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00266	0.00814	CbGpPWpGaD
Bepridil—CALM1—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00265	0.00812	CbGpPWpGaD
Bepridil—CALM2—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00265	0.00812	CbGpPWpGaD
Bepridil—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00255	0.00781	CbGpPWpGaD
Bepridil—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00246	0.00755	CbGpPWpGaD
Bepridil—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00246	0.00755	CbGpPWpGaD
Bepridil—PDE1B—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00243	0.00745	CbGpPWpGaD
Bepridil—Increased appetite—Prednisolone—ankylosing spondylitis	0.00234	0.0122	CcSEcCtD
Bepridil—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00215	0.0113	CcSEcCtD
Bepridil—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00215	0.0112	CcSEcCtD
Bepridil—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00207	0.0108	CcSEcCtD
Bepridil—KCNH2—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00206	0.00631	CbGpPWpGaD
Bepridil—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00195	0.0102	CcSEcCtD
Bepridil—Increased appetite—Betamethasone—ankylosing spondylitis	0.00195	0.0102	CcSEcCtD
Bepridil—Cardiac failure—Betamethasone—ankylosing spondylitis	0.00188	0.00983	CcSEcCtD
Bepridil—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.00188	0.00983	CcSEcCtD
Bepridil—PDE1A—Immune System—KIR3DL1—ankylosing spondylitis	0.00182	0.00559	CbGpPWpGaD
Bepridil—Influenza—Triamcinolone—ankylosing spondylitis	0.00175	0.00914	CcSEcCtD
Bepridil—Increased appetite—Prednisone—ankylosing spondylitis	0.0017	0.00889	CcSEcCtD
Bepridil—PDE1B—Immune System—KIR3DL1—ankylosing spondylitis	0.00167	0.00511	CbGpPWpGaD
Bepridil—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00165	0.00505	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—CARD9—ankylosing spondylitis	0.00164	0.00504	CbGpPWpGaD
Bepridil—Cardiac failure—Prednisone—ankylosing spondylitis	0.00164	0.00856	CcSEcCtD
Bepridil—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	0.0016	0.0049	CbGpPWpGaD
Bepridil—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00159	0.00488	CbGpPWpGaD
Bepridil—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00159	0.00488	CbGpPWpGaD
Bepridil—PDE1A—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00157	0.00482	CbGpPWpGaD
Bepridil—Bradycardia—Prednisolone—ankylosing spondylitis	0.00155	0.0081	CcSEcCtD
Bepridil—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00155	0.00474	CbGpPWpGaD
Bepridil—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00155	0.00474	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.00151	0.00464	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—CARD9—ankylosing spondylitis	0.0015	0.00461	CbGpPWpGaD
Bepridil—Sweating—Methylprednisolone—ankylosing spondylitis	0.00149	0.00779	CcSEcCtD
Bepridil—KCNH2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00148	0.00454	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00147	0.00452	CbGpPWpGaD
Bepridil—PDE1B—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00144	0.00441	CbGpPWpGaD
Bepridil—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00142	0.00744	CcSEcCtD
Bepridil—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00142	0.00743	CcSEcCtD
Bepridil—Rhinitis—Triamcinolone—ankylosing spondylitis	0.0014	0.00733	CcSEcCtD
Bepridil—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.0014	0.00732	CcSEcCtD
Bepridil—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.00139	0.00427	CbGpPWpGaD
Bepridil—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00139	0.00726	CcSEcCtD
Bepridil—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00136	0.0071	CcSEcCtD
Bepridil—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00129	0.00677	CcSEcCtD
Bepridil—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00129	0.00676	CcSEcCtD
Bepridil—Bradycardia—Betamethasone—ankylosing spondylitis	0.00129	0.00676	CcSEcCtD
Bepridil—PDE1A—Disease—ANTXR2—ankylosing spondylitis	0.00128	0.00391	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.00127	0.0039	CbGpPWpGaD
Bepridil—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00127	0.00665	CcSEcCtD
Bepridil—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00125	0.00653	CcSEcCtD
Bepridil—Vision blurred—Prednisolone—ankylosing spondylitis	0.00125	0.00652	CcSEcCtD
Bepridil—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00125	0.00652	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00123	0.00644	CcSEcCtD
Bepridil—Depression—Prednisone—ankylosing spondylitis	0.00123	0.00642	CcSEcCtD
Bepridil—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00121	0.00371	CbGpPWpGaD
Bepridil—Vertigo—Prednisolone—ankylosing spondylitis	0.00119	0.00622	CcSEcCtD
Bepridil—Syncope—Prednisolone—ankylosing spondylitis	0.00119	0.00621	CcSEcCtD
Bepridil—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.00118	0.00363	CbGpPWpGaD
Bepridil—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00117	0.00358	CbGpPWpGaD
Bepridil—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00117	0.00358	CbGpPWpGaD
Bepridil—PDE1B—Disease—ANTXR2—ankylosing spondylitis	0.00117	0.00358	CbGpPWpGaD
Bepridil—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00116	0.00608	CcSEcCtD
Bepridil—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00116	0.00356	CbGpPWpGaD
Bepridil—Hypertension—Prednisolone—ankylosing spondylitis	0.00114	0.00598	CcSEcCtD
Bepridil—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00113	0.00593	CcSEcCtD
Bepridil—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00113	0.00593	CcSEcCtD
Bepridil—Bradycardia—Prednisone—ankylosing spondylitis	0.00112	0.00588	CcSEcCtD
Bepridil—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00112	0.00345	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00112	0.00345	CbGpPWpGaD
Bepridil—CACNA1D—Alzheimers Disease—TNF—ankylosing spondylitis	0.00112	0.00344	CbGpPWpGaD
Bepridil—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00111	0.00578	CcSEcCtD
Bepridil—PDE1A—Immune System—IL1R2—ankylosing spondylitis	0.0011	0.00339	CbGpPWpGaD
Bepridil—Vertigo—Triamcinolone—ankylosing spondylitis	0.00109	0.00572	CcSEcCtD
Bepridil—Syncope—Triamcinolone—ankylosing spondylitis	0.00109	0.00571	CcSEcCtD
Bepridil—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00109	0.00571	CcSEcCtD
Bepridil—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00109	0.00334	CbGpPWpGaD
Bepridil—Syncope—Methylprednisolone—ankylosing spondylitis	0.00109	0.0057	CcSEcCtD
Bepridil—CACNA1A—Metabolism—B3GNT2—ankylosing spondylitis	0.00108	0.00332	CbGpPWpGaD
Bepridil—Oedema—Prednisolone—ankylosing spondylitis	0.00108	0.00565	CcSEcCtD
Bepridil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00107	0.0056	CcSEcCtD
Bepridil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00107	0.00558	CcSEcCtD
Bepridil—Shock—Prednisolone—ankylosing spondylitis	0.00106	0.00556	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00106	0.00556	CcSEcCtD
Bepridil—Cough—Triamcinolone—ankylosing spondylitis	0.00106	0.00556	CcSEcCtD
Bepridil—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00105	0.00323	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00105	0.00323	CbGpPWpGaD
Bepridil—Hypertension—Triamcinolone—ankylosing spondylitis	0.00105	0.0055	CcSEcCtD
Bepridil—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00105	0.00548	CcSEcCtD
Bepridil—PDE1A—Immune System—ERAP1—ankylosing spondylitis	0.00105	0.00321	CbGpPWpGaD
Bepridil—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00104	0.00546	CcSEcCtD
Bepridil—Myalgia—Triamcinolone—ankylosing spondylitis	0.00104	0.00542	CcSEcCtD
Bepridil—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00103	0.00541	CcSEcCtD
Bepridil—PDE1A—Innate Immune System—HLA-C—ankylosing spondylitis	0.00103	0.00316	CbGpPWpGaD
Bepridil—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00103	0.00539	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—ankylosing spondylitis	0.00103	0.00538	CcSEcCtD
Bepridil—Depression—Methotrexate—ankylosing spondylitis	0.00103	0.00536	CcSEcCtD
Bepridil—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00101	0.0053	CcSEcCtD
Bepridil—PDE1B—Immune System—IL1R2—ankylosing spondylitis	0.00101	0.0031	CbGpPWpGaD
Bepridil—Oedema—Triamcinolone—ankylosing spondylitis	0.000994	0.0052	CcSEcCtD
Bepridil—Vertigo—Betamethasone—ankylosing spondylitis	0.000992	0.00519	CcSEcCtD
Bepridil—Vertigo—Dexamethasone—ankylosing spondylitis	0.000992	0.00519	CcSEcCtD
Bepridil—Syncope—Betamethasone—ankylosing spondylitis	0.000991	0.00518	CcSEcCtD
Bepridil—Syncope—Dexamethasone—ankylosing spondylitis	0.000991	0.00518	CcSEcCtD
Bepridil—Arrhythmia—Prednisone—ankylosing spondylitis	0.000987	0.00516	CcSEcCtD
Bepridil—CACNA1C—Alzheimers Disease—TNF—ankylosing spondylitis	0.000986	0.00302	CbGpPWpGaD
Bepridil—Sweating—Methotrexate—ankylosing spondylitis	0.000986	0.00516	CcSEcCtD
Bepridil—Shock—Triamcinolone—ankylosing spondylitis	0.000977	0.00511	CcSEcCtD
Bepridil—Insomnia—Prednisolone—ankylosing spondylitis	0.000977	0.00511	CcSEcCtD
Bepridil—Shock—Methylprednisolone—ankylosing spondylitis	0.000975	0.0051	CcSEcCtD
Bepridil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000971	0.00508	CcSEcCtD
Bepridil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000971	0.00508	CcSEcCtD
Bepridil—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00097	0.00507	CcSEcCtD
Bepridil—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000964	0.00295	CbGpPWpGaD
Bepridil—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000962	0.00295	CbGpPWpGaD
Bepridil—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00096	0.00502	CcSEcCtD
Bepridil—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000958	0.00501	CcSEcCtD
Bepridil—PDE1B—Immune System—ERAP1—ankylosing spondylitis	0.000958	0.00294	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CARD9—ankylosing spondylitis	0.000958	0.00294	CbGpPWpGaD
Bepridil—Hypertension—Betamethasone—ankylosing spondylitis	0.000954	0.00499	CcSEcCtD
Bepridil—Hypertension—Dexamethasone—ankylosing spondylitis	0.000954	0.00499	CcSEcCtD
Bepridil—PDE1B—Innate Immune System—HLA-C—ankylosing spondylitis	0.000944	0.00289	CbGpPWpGaD
Bepridil—Myalgia—Dexamethasone—ankylosing spondylitis	0.00094	0.00492	CcSEcCtD
Bepridil—Myalgia—Betamethasone—ankylosing spondylitis	0.00094	0.00492	CcSEcCtD
Bepridil—Anxiety—Dexamethasone—ankylosing spondylitis	0.000937	0.0049	CcSEcCtD
Bepridil—Anxiety—Betamethasone—ankylosing spondylitis	0.000937	0.0049	CcSEcCtD
Bepridil—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000932	0.00286	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000932	0.00286	CbGpPWpGaD
Bepridil—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000931	0.00285	CbGpPWpGaD
Bepridil—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000931	0.00285	CbGpPWpGaD
Bepridil—Pain—Prednisolone—ankylosing spondylitis	0.000924	0.00483	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000917	0.00479	CcSEcCtD
Bepridil—CACNA2D2—Metabolism—B3GNT2—ankylosing spondylitis	0.000908	0.00278	CbGpPWpGaD
Bepridil—Vision blurred—Prednisone—ankylosing spondylitis	0.000907	0.00474	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000905	0.00473	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000903	0.00472	CcSEcCtD
Bepridil—Oedema—Dexamethasone—ankylosing spondylitis	0.000901	0.00471	CcSEcCtD
Bepridil—Oedema—Betamethasone—ankylosing spondylitis	0.000901	0.00471	CcSEcCtD
Bepridil—Insomnia—Triamcinolone—ankylosing spondylitis	0.000899	0.0047	CcSEcCtD
Bepridil—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000897	0.00469	CcSEcCtD
Bepridil—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000892	0.00467	CcSEcCtD
Bepridil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00089	0.00465	CcSEcCtD
Bepridil—Shock—Dexamethasone—ankylosing spondylitis	0.000887	0.00464	CcSEcCtD
Bepridil—Shock—Betamethasone—ankylosing spondylitis	0.000887	0.00464	CcSEcCtD
Bepridil—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000886	0.00463	CcSEcCtD
Bepridil—PDE1B—Immune System—CARD9—ankylosing spondylitis	0.000876	0.00268	CbGpPWpGaD
Bepridil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000875	0.00457	CcSEcCtD
Bepridil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000873	0.00456	CcSEcCtD
Bepridil—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000871	0.00456	CcSEcCtD
Bepridil—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000871	0.00456	CcSEcCtD
Bepridil—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000871	0.00267	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000866	0.00265	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000866	0.00265	CbGpPWpGaD
Bepridil—Vertigo—Prednisone—ankylosing spondylitis	0.000864	0.00452	CcSEcCtD
Bepridil—Syncope—Prednisone—ankylosing spondylitis	0.000863	0.00451	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—ankylosing spondylitis	0.000861	0.0045	CcSEcCtD
Bepridil—Anorexia—Dexamethasone—ankylosing spondylitis	0.000859	0.00449	CcSEcCtD
Bepridil—Anorexia—Betamethasone—ankylosing spondylitis	0.000859	0.00449	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000857	0.00448	CcSEcCtD
Bepridil—Pain—Triamcinolone—ankylosing spondylitis	0.00085	0.00444	CcSEcCtD
Bepridil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000845	0.00442	CcSEcCtD
Bepridil—Hypertension—Prednisone—ankylosing spondylitis	0.00083	0.00434	CcSEcCtD
Bepridil—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000827	0.00254	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000823	0.00252	CbGpPWpGaD
Bepridil—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000821	0.00429	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000821	0.00429	CcSEcCtD
Bepridil—Myalgia—Prednisone—ankylosing spondylitis	0.000819	0.00428	CcSEcCtD
Bepridil—Anxiety—Prednisone—ankylosing spondylitis	0.000816	0.00427	CcSEcCtD
Bepridil—Insomnia—Betamethasone—ankylosing spondylitis	0.000815	0.00426	CcSEcCtD
Bepridil—Insomnia—Dexamethasone—ankylosing spondylitis	0.000815	0.00426	CcSEcCtD
Bepridil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000811	0.00424	CcSEcCtD
Bepridil—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000809	0.00423	CcSEcCtD
Bepridil—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000809	0.00423	CcSEcCtD
Bepridil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000794	0.00415	CcSEcCtD
Bepridil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000794	0.00415	CcSEcCtD
Bepridil—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000785	0.00411	CcSEcCtD
Bepridil—Oedema—Prednisone—ankylosing spondylitis	0.000785	0.00411	CcSEcCtD
Bepridil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000784	0.0041	CcSEcCtD
Bepridil—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000784	0.0041	CcSEcCtD
Bepridil—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000784	0.0041	CcSEcCtD
Bepridil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000778	0.00407	CcSEcCtD
Bepridil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000778	0.00407	CcSEcCtD
Bepridil—Shock—Prednisone—ankylosing spondylitis	0.000772	0.00404	CcSEcCtD
Bepridil—Pain—Betamethasone—ankylosing spondylitis	0.000771	0.00403	CcSEcCtD
Bepridil—Pain—Dexamethasone—ankylosing spondylitis	0.000771	0.00403	CcSEcCtD
Bepridil—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000763	0.00234	CbGpPWpGaD
Bepridil—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000759	0.00397	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—ankylosing spondylitis	0.000758	0.00396	CcSEcCtD
Bepridil—PDE1A—Disease—B3GNT2—ankylosing spondylitis	0.000752	0.0023	CbGpPWpGaD
Bepridil—Anorexia—Prednisone—ankylosing spondylitis	0.000748	0.00391	CcSEcCtD
Bepridil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000737	0.00385	CcSEcCtD
Bepridil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000737	0.00385	CcSEcCtD
Bepridil—Vertigo—Methotrexate—ankylosing spondylitis	0.000722	0.00378	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000715	0.00374	CcSEcCtD
Bepridil—Dizziness—Prednisolone—ankylosing spondylitis	0.000714	0.00374	CcSEcCtD
Bepridil—Asthenia—Triamcinolone—ankylosing spondylitis	0.000713	0.00373	CcSEcCtD
Bepridil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000713	0.00373	CcSEcCtD
Bepridil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000713	0.00373	CcSEcCtD
Bepridil—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000713	0.00373	CcSEcCtD
Bepridil—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000713	0.00373	CcSEcCtD
Bepridil—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000711	0.00372	CcSEcCtD
Bepridil—Insomnia—Prednisone—ankylosing spondylitis	0.00071	0.00371	CcSEcCtD
Bepridil—Paraesthesia—Prednisone—ankylosing spondylitis	0.000705	0.00369	CcSEcCtD
Bepridil—Cough—Methotrexate—ankylosing spondylitis	0.000702	0.00367	CcSEcCtD
Bepridil—Dyspepsia—Prednisone—ankylosing spondylitis	0.000691	0.00361	CcSEcCtD
Bepridil—PDE1B—Disease—B3GNT2—ankylosing spondylitis	0.000688	0.00211	CbGpPWpGaD
Bepridil—Myalgia—Methotrexate—ankylosing spondylitis	0.000684	0.00358	CcSEcCtD
Bepridil—Decreased appetite—Prednisone—ankylosing spondylitis	0.000682	0.00357	CcSEcCtD
Bepridil—Rash—Prednisolone—ankylosing spondylitis	0.000681	0.00356	CcSEcCtD
Bepridil—Dermatitis—Prednisolone—ankylosing spondylitis	0.000681	0.00356	CcSEcCtD
Bepridil—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.00068	0.00208	CbGpPWpGaD
Bepridil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000678	0.00355	CcSEcCtD
Bepridil—Headache—Prednisolone—ankylosing spondylitis	0.000677	0.00354	CcSEcCtD
Bepridil—PDE1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000673	0.00206	CbGpPWpGaD
Bepridil—Constipation—Prednisone—ankylosing spondylitis	0.000671	0.00351	CcSEcCtD
Bepridil—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.000661	0.00203	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.000658	0.00202	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.000658	0.00202	CbGpPWpGaD
Bepridil—Dizziness—Triamcinolone—ankylosing spondylitis	0.000657	0.00344	CcSEcCtD
Bepridil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000656	0.00343	CcSEcCtD
Bepridil—Asthenia—Betamethasone—ankylosing spondylitis	0.000647	0.00338	CcSEcCtD
Bepridil—Asthenia—Dexamethasone—ankylosing spondylitis	0.000647	0.00338	CcSEcCtD
Bepridil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000642	0.00336	CcSEcCtD
Bepridil—Nausea—Prednisolone—ankylosing spondylitis	0.000642	0.00336	CcSEcCtD
Bepridil—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000639	0.00196	CbGpPWpGaD
Bepridil—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000639	0.00196	CbGpPWpGaD
Bepridil—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000634	0.00332	CcSEcCtD
Bepridil—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000627	0.00192	CbGpPWpGaD
Bepridil—Rash—Triamcinolone—ankylosing spondylitis	0.000626	0.00328	CcSEcCtD
Bepridil—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000626	0.00192	CbGpPWpGaD
Bepridil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000626	0.00327	CcSEcCtD
Bepridil—Anorexia—Methotrexate—ankylosing spondylitis	0.000625	0.00327	CcSEcCtD
Bepridil—Rash—Methylprednisolone—ankylosing spondylitis	0.000625	0.00327	CcSEcCtD
Bepridil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000624	0.00327	CcSEcCtD
Bepridil—Headache—Triamcinolone—ankylosing spondylitis	0.000622	0.00325	CcSEcCtD
Bepridil—Headache—Methylprednisolone—ankylosing spondylitis	0.000621	0.00325	CcSEcCtD
Bepridil—Body temperature increased—Prednisone—ankylosing spondylitis	0.000621	0.00325	CcSEcCtD
Bepridil—Abdominal pain—Prednisone—ankylosing spondylitis	0.000621	0.00325	CcSEcCtD
Bepridil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000617	0.00323	CcSEcCtD
Bepridil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000617	0.00323	CcSEcCtD
Bepridil—PDE1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000616	0.00189	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000611	0.00187	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—HLA-B—ankylosing spondylitis	0.000611	0.00187	CbGpPWpGaD
Bepridil—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000606	0.00186	CbGpPWpGaD
Bepridil—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000606	0.00186	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000606	0.00186	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000606	0.00186	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-C—ankylosing spondylitis	0.000601	0.00184	CbGpPWpGaD
Bepridil—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000598	0.00313	CcSEcCtD
Bepridil—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.000596	0.00183	CbGpPWpGaD
Bepridil—Dizziness—Betamethasone—ankylosing spondylitis	0.000596	0.00312	CcSEcCtD
Bepridil—Dizziness—Dexamethasone—ankylosing spondylitis	0.000596	0.00312	CcSEcCtD
Bepridil—Insomnia—Methotrexate—ankylosing spondylitis	0.000593	0.0031	CcSEcCtD
Bepridil—Nausea—Triamcinolone—ankylosing spondylitis	0.00059	0.00309	CcSEcCtD
Bepridil—CACNA1D—Metabolism—B3GNT2—ankylosing spondylitis	0.00059	0.00181	CbGpPWpGaD
Bepridil—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000589	0.00308	CcSEcCtD
Bepridil—Nausea—Methylprednisolone—ankylosing spondylitis	0.000589	0.00308	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000585	0.00306	CcSEcCtD
Bepridil—Somnolence—Methotrexate—ankylosing spondylitis	0.000583	0.00305	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000578	0.00302	CcSEcCtD
Bepridil—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.000577	0.00177	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.000577	0.00177	CbGpPWpGaD
Bepridil—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00057	0.00298	CcSEcCtD
Bepridil—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00057	0.00175	CbGpPWpGaD
Bepridil—Rash—Dexamethasone—ankylosing spondylitis	0.000568	0.00297	CcSEcCtD
Bepridil—Rash—Betamethasone—ankylosing spondylitis	0.000568	0.00297	CcSEcCtD
Bepridil—Dermatitis—Betamethasone—ankylosing spondylitis	0.000568	0.00297	CcSEcCtD
Bepridil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000568	0.00297	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000566	0.00296	CcSEcCtD
Bepridil—Headache—Betamethasone—ankylosing spondylitis	0.000565	0.00295	CcSEcCtD
Bepridil—Headache—Dexamethasone—ankylosing spondylitis	0.000565	0.00295	CcSEcCtD
Bepridil—Asthenia—Prednisone—ankylosing spondylitis	0.000563	0.00295	CcSEcCtD
Bepridil—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000562	0.00172	CbGpPWpGaD
Bepridil—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000562	0.00172	CbGpPWpGaD
Bepridil—Pain—Methotrexate—ankylosing spondylitis	0.000561	0.00293	CcSEcCtD
Bepridil—KCNH2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000561	0.00172	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000559	0.00171	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—HLA-B—ankylosing spondylitis	0.000558	0.00171	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000551	0.00169	CbGpPWpGaD
Bepridil—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000551	0.00169	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-C—ankylosing spondylitis	0.00055	0.00169	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—CRP—ankylosing spondylitis	0.00054	0.00165	CbGpPWpGaD
Bepridil—Diarrhoea—Prednisone—ankylosing spondylitis	0.000537	0.00281	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000537	0.00281	CcSEcCtD
Bepridil—Nausea—Dexamethasone—ankylosing spondylitis	0.000535	0.0028	CcSEcCtD
Bepridil—Nausea—Betamethasone—ankylosing spondylitis	0.000535	0.0028	CcSEcCtD
Bepridil—PDE1A—Immune System—IL1RN—ankylosing spondylitis	0.000522	0.0016	CbGpPWpGaD
Bepridil—Dizziness—Prednisone—ankylosing spondylitis	0.000519	0.00271	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000519	0.00271	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000519	0.00271	CcSEcCtD
Bepridil—CACNA1C—Metabolism—B3GNT2—ankylosing spondylitis	0.000518	0.00159	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—TLR4—ankylosing spondylitis	0.000517	0.00159	CbGpPWpGaD
Bepridil—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000502	0.00154	CbGpPWpGaD
Bepridil—Rash—Prednisone—ankylosing spondylitis	0.000495	0.00259	CcSEcCtD
Bepridil—Dermatitis—Prednisone—ankylosing spondylitis	0.000495	0.00259	CcSEcCtD
Bepridil—PDE1B—Innate Immune System—CRP—ankylosing spondylitis	0.000494	0.00151	CbGpPWpGaD
Bepridil—Headache—Prednisone—ankylosing spondylitis	0.000492	0.00257	CcSEcCtD
Bepridil—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000486	0.00149	CbGpPWpGaD
Bepridil—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000486	0.00149	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL1RN—ankylosing spondylitis	0.000478	0.00146	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—TLR4—ankylosing spondylitis	0.000473	0.00145	CbGpPWpGaD
Bepridil—Asthenia—Methotrexate—ankylosing spondylitis	0.000471	0.00246	CcSEcCtD
Bepridil—Nausea—Prednisone—ankylosing spondylitis	0.000466	0.00244	CcSEcCtD
Bepridil—CALM3—Disease—ANTXR2—ankylosing spondylitis	0.000463	0.00142	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD79A—ankylosing spondylitis	0.000459	0.00141	CbGpPWpGaD
Bepridil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000449	0.00235	CcSEcCtD
Bepridil—CALM2—Disease—ANTXR2—ankylosing spondylitis	0.000447	0.00137	CbGpPWpGaD
Bepridil—CALM1—Disease—ANTXR2—ankylosing spondylitis	0.000447	0.00137	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000435	0.00133	CbGpPWpGaD
Bepridil—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	0.000435	0.00133	CbGpPWpGaD
Bepridil—Dizziness—Methotrexate—ankylosing spondylitis	0.000434	0.00227	CcSEcCtD
Bepridil—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	0.000421	0.00129	CbGpPWpGaD
Bepridil—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	0.000421	0.00129	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD79A—ankylosing spondylitis	0.000419	0.00129	CbGpPWpGaD
Bepridil—Rash—Methotrexate—ankylosing spondylitis	0.000414	0.00216	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—ankylosing spondylitis	0.000413	0.00216	CcSEcCtD
Bepridil—Headache—Methotrexate—ankylosing spondylitis	0.000411	0.00215	CcSEcCtD
Bepridil—CALM3—Immune System—IL1R2—ankylosing spondylitis	0.0004	0.00123	CbGpPWpGaD
Bepridil—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.0004	0.00123	CbGpPWpGaD
Bepridil—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.0004	0.00123	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000398	0.00122	CbGpPWpGaD
Bepridil—Nausea—Methotrexate—ankylosing spondylitis	0.00039	0.00204	CcSEcCtD
Bepridil—CALM1—Immune System—IL1R2—ankylosing spondylitis	0.000387	0.00119	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1R2—ankylosing spondylitis	0.000387	0.00119	CbGpPWpGaD
Bepridil—CALM3—Immune System—ERAP1—ankylosing spondylitis	0.00038	0.00116	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL1A—ankylosing spondylitis	0.000376	0.00115	CbGpPWpGaD
Bepridil—CACNA1H—Developmental Biology—TNF—ankylosing spondylitis	0.000376	0.00115	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	0.000374	0.00115	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD40LG—ankylosing spondylitis	0.000374	0.00115	CbGpPWpGaD
Bepridil—CALM1—Immune System—ERAP1—ankylosing spondylitis	0.000367	0.00113	CbGpPWpGaD
Bepridil—CALM2—Immune System—ERAP1—ankylosing spondylitis	0.000367	0.00113	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000362	0.00111	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	0.000362	0.00111	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000361	0.00111	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00036	0.0011	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-B—ankylosing spondylitis	0.000356	0.00109	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000348	0.00107	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000348	0.00107	CbGpPWpGaD
Bepridil—CALM3—Immune System—CARD9—ankylosing spondylitis	0.000347	0.00106	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL1A—ankylosing spondylitis	0.000344	0.00105	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD40LG—ankylosing spondylitis	0.000342	0.00105	CbGpPWpGaD
Bepridil—CALM2—Immune System—CARD9—ankylosing spondylitis	0.000336	0.00103	CbGpPWpGaD
Bepridil—CALM1—Immune System—CARD9—ankylosing spondylitis	0.000336	0.00103	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00033	0.00101	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-A—ankylosing spondylitis	0.000329	0.00101	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	0.000329	0.00101	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-B—ankylosing spondylitis	0.000325	0.000997	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CRP—ankylosing spondylitis	0.000314	0.000963	CbGpPWpGaD
Bepridil—PDE1A—Disease—HLA-A—ankylosing spondylitis	0.000304	0.000932	CbGpPWpGaD
Bepridil—PDE1A—Immune System—TLR4—ankylosing spondylitis	0.000301	0.000924	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-A—ankylosing spondylitis	0.000301	0.000924	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CRP—ankylosing spondylitis	0.000287	0.000881	CbGpPWpGaD
Bepridil—PDE1B—Disease—HLA-A—ankylosing spondylitis	0.000278	0.000853	CbGpPWpGaD
Bepridil—PDE1B—Immune System—TLR4—ankylosing spondylitis	0.000276	0.000845	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000274	0.00084	CbGpPWpGaD
Bepridil—CALM3—Disease—B3GNT2—ankylosing spondylitis	0.000273	0.000836	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000265	0.000813	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000265	0.000813	CbGpPWpGaD
Bepridil—CALM1—Disease—B3GNT2—ankylosing spondylitis	0.000264	0.000808	CbGpPWpGaD
Bepridil—CALM2—Disease—B3GNT2—ankylosing spondylitis	0.000264	0.000808	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—TNF—ankylosing spondylitis	0.000259	0.000794	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000257	0.000788	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000235	0.000721	CbGpPWpGaD
Bepridil—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	0.000228	0.0007	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—TNF—ankylosing spondylitis	0.000228	0.000698	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000224	0.000685	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000222	0.000679	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	0.000221	0.000679	CbGpPWpGaD
Bepridil—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	0.000221	0.000677	CbGpPWpGaD
Bepridil—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	0.000221	0.000677	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-C—ankylosing spondylitis	0.000218	0.000668	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000216	0.000663	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000216	0.000663	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000214	0.000657	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000214	0.000657	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	0.000214	0.000656	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000214	0.000656	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000213	0.000652	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-C—ankylosing spondylitis	0.000211	0.000647	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-C—ankylosing spondylitis	0.000211	0.000647	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000206	0.00063	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000206	0.00063	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000197	0.000604	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CRP—ankylosing spondylitis	0.000196	0.0006	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000191	0.000584	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000191	0.000584	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1RN—ankylosing spondylitis	0.000189	0.000581	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CRP—ankylosing spondylitis	0.000189	0.00058	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CRP—ankylosing spondylitis	0.000189	0.00058	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	0.000188	0.000575	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1RN—ankylosing spondylitis	0.000183	0.000562	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1RN—ankylosing spondylitis	0.000183	0.000562	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	0.000181	0.000556	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	0.000181	0.000556	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	0.000173	0.00053	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD79A—ankylosing spondylitis	0.000166	0.00051	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	0.000163	0.0005	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000163	0.000498	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD79A—ankylosing spondylitis	0.000161	0.000493	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD79A—ankylosing spondylitis	0.000161	0.000493	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000158	0.000484	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000153	0.000468	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000153	0.000468	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1A—ankylosing spondylitis	0.000136	0.000418	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD40LG—ankylosing spondylitis	0.000136	0.000416	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1A—ankylosing spondylitis	0.000132	0.000404	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1A—ankylosing spondylitis	0.000132	0.000404	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD40LG—ankylosing spondylitis	0.000131	0.000402	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD40LG—ankylosing spondylitis	0.000131	0.000402	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000131	0.000401	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-B—ankylosing spondylitis	0.000129	0.000395	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000127	0.000388	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000127	0.000388	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-B—ankylosing spondylitis	0.000125	0.000382	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-B—ankylosing spondylitis	0.000125	0.000382	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-A—ankylosing spondylitis	0.000119	0.000366	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-A—ankylosing spondylitis	0.000116	0.000354	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-A—ankylosing spondylitis	0.000116	0.000354	CbGpPWpGaD
Bepridil—CALM3—Immune System—CRP—ankylosing spondylitis	0.000114	0.000349	CbGpPWpGaD
Bepridil—CALM3—Disease—HLA-A—ankylosing spondylitis	0.00011	0.000338	CbGpPWpGaD
Bepridil—CALM2—Immune System—CRP—ankylosing spondylitis	0.00011	0.000338	CbGpPWpGaD
Bepridil—CALM1—Immune System—CRP—ankylosing spondylitis	0.00011	0.000338	CbGpPWpGaD
Bepridil—CALM3—Immune System—TLR4—ankylosing spondylitis	0.000109	0.000335	CbGpPWpGaD
Bepridil—CALM2—Disease—HLA-A—ankylosing spondylitis	0.000107	0.000327	CbGpPWpGaD
Bepridil—CALM1—Disease—HLA-A—ankylosing spondylitis	0.000107	0.000327	CbGpPWpGaD
Bepridil—CALM2—Immune System—TLR4—ankylosing spondylitis	0.000106	0.000324	CbGpPWpGaD
Bepridil—CALM1—Immune System—TLR4—ankylosing spondylitis	0.000106	0.000324	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	9.32e-05	0.000286	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	9.02e-05	0.000276	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	9.02e-05	0.000276	CbGpPWpGaD
